Nivolumab gives renal cancer survivor a second chance
Tennessee resident Philip Prichard hadn’t even heard of immunotherapy or Nivolumab when he was first diagnosed with kidney cancer in the summer of 2012.
But it’s precisely that drug and groundbreaking type of cancer treatment that eventually saved his life.
Unexpected detour
Philip was on his way home from a business trip to South Carolina when he began feeling pain in his right side and leg. He told his wife he wasn...